Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries
Related Posts
Pikoulas A, Morianos I, Nidris V, Hamdy R, Intze E, López-López Á, Moran-Garrido M, Muthu V, Halabalaki M, Papaioanou V, Papadovasilaki M, Kyrmizi I, Gu[...]
Takahashi H, Harada N, Hayamizu Y, Dungubat E, Nakazawa M, Kitakaze T, Sugimoto K, Inui H, Yoshihara E, Takahashi Y, Yamaji R. Testosterone deficiency synergistically[...]
Tamarappoo B, Wolny R, Tomasino GF, Berman D, Handberg E, Pepine CJ, Lo MC, Budoff M, Shaw L, Shufelt C, Wei J, Gulati M, Merz[...]